Tag: Innovative Medicines

Otsuka extended collaboration on digital medicines with Proteus Digital Health

digital-drug
Otsuka Pharmaceutical and Proteus Digital Health announce the signing of an expanded global collaboration agreement that will strengthen the relationship between the two companies.

MEI Pharma and BeiGene will jointly develop cancer drugs

laboratory test
MEI Pharma and BeiGene announced a clinical collaboration to evaluate the safety and efficacy of MEI's ME-401 in combination with BeiGene's zanubrutinib.

Researchers unveiled the first bio-electronic medicine

digital drug
Researchers at Northwestern University and Washington University School of Medicine have developed the first example of a bioresorbable electronic medicine.

Manturov: By launching innovative drugs, we will ensure a fold increase in exports

drug
The export of Russian pharmaceutical products in the coming years will increase several-fold and in five years will reach $ 3-4 billion a year through the launch of innovative drugs,

Sinopharm and Oramed received $600 million for their oral insulin candidate

oral-insulin
Harbin Gloria Pharmaceuticals took a $600 million stake in a subsidiary of SINOPHARM GROUP whose lead product is an oral insulin candidate being codeveloped with Israeli biotech Oramed Pharmaceuticals.

GSK and 23andMe entered an exclusive R&D collaboration

gsk
GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the basis for discovery.

Anima Biotech signs a drug discovery agreement with Lilly

drug-development
Anima Biotech announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima's Translation Control Therapeutics platform.

PureTech Health entered into a multiyear collaboration with Roche

microscope
PureTech Health, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut (BIG) Axis, announced that it has entered into a multiyear collaboration with Roche.

South Korean company acquires AMPAC Fine Chemicals

api
SK Holdings, the parent company of South Korea’s third-largest conglomerate SK Group, announced that it has acquired a 100 percent stake in AMPAC Fine Chemicals, a US-based contract manufacturer of APIs.

Harvard researchers developed a new method to deliver insulin orally

lab-tubes
Scientists at the Harvard John A. Paulson School of Engineering and Applied Sciences have developed an oral delivery method that could dramatically transform the way in which diabetics keep their blood sugar levels in check.

Juvenescence receives $50 million to develop anti-aging therapies

antii-aging
Juvenescence Limited, a leader in the development of therapies to slow, halt or potentially reverse aging, has successfully raised $50 million in its Series A financing.

Vetter launches the Open Innovation Challenge

lab research
The purpose of the challenge is to develop innovative, future-focused and sustainable solutions for the injection of medicines that are even better streamlined to user needs than current methods.

Celltrion and Yonsei University Health System will develop new biopharmaceuticals

celltrion
Celltrion signed an agreement with Yonsei University Health System on the joint development of Fc-Saxatilin, a candidate drug for ischemic strokes in a bid to develop new biopharmaceuticals for cerebrovascular diseases.

Eligo Bioscience received financing to strengthen its biotherapeutic platform

microbiome
Eligo Bioscience, the French microbiome company, has secured a $20 million Series A round of financing from Khosla Ventures and Seventure Partners, including a $2 million award from the Worldwide Innovation Challenge.

Cerenis Therapeutics and UNTHSC will jointly develop HDL-based pharma products

hdl-cholesterol
CERENIS Therapeutics, an international biopharmaceutical company dedicated to the development of HDL-based innovative therapies, signed a strategic partnership with the University of North Texas Health Science Center.

Novel medicines development company Brii Bio launches in China

drug development
Brii Bio, a Chinese company committed to serving patients’ needs and improving public health, announced its launch with significant partnerships and financing.